- ROUNDTABLE: Pharmacy’s future in sync with technology
- President Obama addresses health reform during State of the Union, industry responds
- CVS' Merlo: Health reform to benefit business in 2014
- USPLabs agrees to recall and destroy dietary supplement following FDA actions
- Bloomberg: Greg Wasson joins thought leaders to discuss the state of health care in the United States
SILVER SPRING, Md. — The Food and Drug Administration has appointed a new chief of staff for commissioner Margaret Hamburg, according to a letter sent to agency employees Monday.
In the letter, Hamburg announced the appointment of Lisa Barclay. Barclay, currently a partner at the Washington law firm Zuckerman Spaeder, will replace Molly Muldoon, who was previously chief of staff and more recently the agency's acting COO.
Barclay previously worked with the FDA in the 1990s, with the Commissioner's Office of Policy, and also has worked on Capitol Hill and as a law clerk for senior judge William Bryant of the U.S. District Court for the District of Columbia.